- €1.82bn
- €2.05bn
- €493.13m
Brief: Gimv Acquires Majority Stake In Witec
Brief: Gimv Leads A Eur 72 Mln Series A Financing Round Of Complement Therapeutics
Brief: Gimv Participates In Paleo's Series A Of EUR 12 Mln
Brief: Avedon Acquires Gimv’S Majority Stake In Kind Technologies
Brief: Gimv Announces Partnership With Rohrleitungsbau Münster
Brief: Gimv Exits Biolam To Its Management Backed By Investors
Brief: Gimv End-Sept Net Result Group Share Loss Of EUR 75 Million
French and Benelux stocks-Factors to watch
Brief: Gimv Supports Groupe Claire's Acquisition Of E.I.E. From Veolia's Sade
Brief: Gimv Partners With Founders Of Les Psy Réunis Group To Develop Outpatient Mental Care Provider
Brief: Gimv To Sell Its Share In Eurocept Group Back To Founder Mike Van Woensel
Brief: Gimv Takes Significant Interest In Picot
Brief: Gimv Becomes Majority Owner Of Germany's Variotech
Brief: Gimv FY Net Result At EUR 174.3 Million
Brief: Gimv Acquires Majority Stake In Variass
Brief: Pharming Group Announces Change In Its Holding In BioConnection
Brief: Gimv Announces The Creation Of Olyn Group
Brief: Gimv Sells Fire Protection Specialist Incendin
Brief: Gimv Says Biolam To Open 6 New Laboratories in 2022